Ostinato, by English Anonymous, Francisco Correa de Arauxo, Andrea Falconieri, Hesperion XXI, Biagio Marini, Tarquinio Merula, Diego Ortiz, Johann Pachelbel, Henry Purcell, and Salomone Rossi -- $21.98
Schubert: Quintet in C D. 956; The Shepherd on the Rock, by Franz Schubert, Pamela Frank, Felix Galimir, Julia Lichten, Yo-Yo Ma, Steven Tenenbom, Peter Wiley, Benita Valente, Harold Wright, and Rudolf Serkin -- $9.98
Giuseppe Di Stefano Sings Neopolitan & Other Songs, by Arturo Buzzi-Peccia, Pasquale Mario Costa, Ernesto de Curtis, Luigi Denza, Salve Esposito, Rodolfo Falvo, Stanislao Gastaldon, Joseph Giuseppe Gioe, Ruggero Leoncavallo, and Emanuele Nutile -- $22.98
Music for the Spanish Kings, by Anonymous, Canciero de Montecassino Anonymous, Antonio de Cabezon, Johannes Cornago, Antonio Cornazano, Guglielmo Ebreo da Pesaro, Nicolas Gombert, Giovanni Domenico del Giovane da Nola, Diego Ortiz, and Antonio Valente -- $7.99
Schubert: Masses Nos. 2 & 6, by Myron Myers, William Stone, Franz Schubert, Robert Shaw, Marietta Simpson, Atlanta Symphony Orchestra & Chorus, Benita Valente, Dawn Upshaw, David Gordon, and Jon Humphrey -- $14.99
DUBLIN, Ireland----Research and Markets has announced the addition of Alzheimers and Parkinsons Disease - Global Strategic Business Report to their offering.
S&P lowered the company\'s corporate credit rating to \'B+\' from \'BB-\'. \"The ratings downgrade reflects our concern regarding specialty pharmaceutical company Valeant\'s continued struggles to generate earnings and cash flow growth,\" S&P credit analyst Arthur Wong said in a statement.
Standard & Poor's Ratings Services on Friday lowered its ratings on drug developer Valeant Pharmaceuticals International Friday, citing profit concerns.
Senetek PLC , http://www.senetekplc.com/, a life sciences product development company targeting the science of aging to include skincare and dermatological therapeutics, erectile dysfunction, nutrition and cancer, today announced results for the third quarter ended September 30, 2006.
Senetek PLC , a life sciences product development company, today announced that it will report its third quarter 2006 results on Tuesday, November 14, 2006, following the close of trading.
Senetek PLC , a life sciences product development company, today announced agreements with the Institute of Bioorganic Chemistry of the Polish Academy of Sciences in Poznan, Poland for the exclusive rights to anticancer technology for the treatment of brain tumors using interference RNA, as well as exclusive rights to three compounds for the treatment of skin aging.
By Jan Norman, The Orange County Register, Calif. Nov. 2--Valeant Pharmaceuticals International in Costa Mesa said its profits were $11.5 million on sales of $219 million for the third quarter that ended Sept. 30.